According to a new regulatory document, Viola Life Sciences, a start-up company of microbial components and diagnostics in Seattle, is raising more funds.
According to the documents, US $67 million was raised in a larger round of financing. We have contacted Viome for more information and will update it when we receive a reply.
Viam sells a kit to detect the microbial composition of stool samples and recommends “accurate” supplements and probiotics based on personal readings. In July this year, the company released a “whole body intelligence test”, which also analyzes saliva and blood samples. Earlier this year, celebrity and socialite Paris Hilton became the brand ambassador of Viam.
The company is also developing a diagnostic test for oral and laryngeal cancer, which has won the breakthrough equipment name of the US Food and Drug Administration (FDA), enabling it to be quickly evaluated before approval.
In April 2021, the company with a history of six years said that it had more than 200000 customers, and its revenue was expected to reach 100 million dollars in 2022.
Viome is the seventh joint venture of Naveen Jain, founder and CEO. Jain is the founder and former CEO of InfoSpace, as well as the co-founder of Intelius and Moon Express, a public record company, which aims to bring paying customers to the moon.
Viome raised $54 million in November, making its total capital more than $125 million.
Viome’s investors include Salesforce CEO Marc Benioff, Khosla Ventures, WestRiver Group, Glico, Physical Partners, Bold Capital Group and Ocgrow Ventures.
